30th Jun 2015 08:31
LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Tuesday that it has seen "further solid trading" in the first half of its current year, as the success it achieved in 2014 has continued into 2015.
In a statement ahead of the company's annual general meeting, Venn said that its capacity to win larger contracts was reinforced by EUR4.1 million of contract wins in March with a US biotechnology company, and a recent EUR2 million contract win with a European biotechnology company.
"Our new business success rate to date has been encouraging, and we have a good pipeline of potential contracts that we are working hard to convert," said Chief Executive Officer Tony Richardson in the statement.
It is continuing to make progress with its human skin equivalent Labskin following its first sales, and said it is confident for "commercial success this year with these products." Venn also continuing to look at "a number" of acquisition opportunities.
Shares in Venn Life Sciences are trading up 1.2% at 20.23 pence Tuesday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Venn Life Sciences